An effort to develop synthetic vocal cords to heal the voices of people with scarred natural vocal tissues is the topic of the latest episode of the American Chemical Society's (ACS') Bytesize Science series.

STAINES, England, October 21, 2011 /PRNewswire/ -- ?Astellas Pharma Europe Ltd.

STAINES, England, September 21, 2011 /PRNewswire/ -- Astellas Pharma Europe Ltd.

WALTHAM, Mass., March 29, 2011 /PRNewswire/ -- MicroCHIPS, Inc., a developer of innovative drug delivery devices and biosensors, today announced that the U.S. Patent Office and Trademark Office has granted U.S. Patent No. 7,892,221, Method of Controlled Drug Delivery from Implant Device.

BOSTON, Jan. 10, 2011 /PRNewswire/ -- Entrega, Inc., a new company developing oral drug delivery technologies, today announced its formation by Enlight Biosciences, a Boston-based company established in partnership with a group of leading global pharmaceutical companies.